Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1228 |
|---|---|
| Identifier | NCT03596645 |
| Trial Title | A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Golimumab|DRUG: Infliximab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-10-29 |
|---|---|
| Primary Completion Date | 2023-11-21 |
| Completion Date | 2027-08-31 |